Metraipolis › archive › dc_b31e12e93c2f

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction — Europe PMC PMID:33616039

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33616039
DOI
10.7554/elife.64611
License (as archived)
CC0-1.0
Archived
2026-11-05T20:38:10.437Z
SHA-256 of the archived text
f3a7caf6d347c457431ebb0705b79346587519d0d617ffd9dbaf655f9fc90893
Stable URL of this page
https://metraipolis.com/documento/dc_b31e12e93c2f

How to cite

Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction — Europe PMC PMID:33616039 — Europe PMC (en), https://europepmc.org/article/MED/33616039 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b31e12e93c2f (Metraipolis archive dc_b31e12e93c2f, sha256 f3a7caf6d347c457431ebb0705b79346587519d0d617ffd9dbaf655f9fc90893)
BibTeX
@misc{dcb31e12e93c2f,
  title = {Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction — Europe PMC PMID:33616039},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33616039},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b31e12e93c2f; sha256 f3a7caf6d347c457431ebb0705b79346587519d0d617ffd9dbaf655f9fc90893},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33616039. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Metabolic reprogramming between resistance and tolerance occurs within the immune system in response to sepsis. While metabolic tissues such as the liver are subjected to damage during sepsis, how their metabolic and energy reprogramming ensures survival is unclear. Employing comprehensive metabolomic, lipidomic, and transcriptional profiling in a mouse model of sepsis, we show that hepatocyte lipid metabolism, mitochondrial tricarboxylic acid (TCA) energetics, and redox balance are significantly reprogrammed after cecal ligation and puncture (CLP). We identify increases in TCA cycle metabolites citrate, cis-aconitate, and itaconate with reduced fumarate and triglyceride accumulation in septic hepatocytes. Transcriptomic analysis of liver tissue supports and extends the hepatocyte findings. Strikingly, the administration of the pyruvate dehydrogenase kinase (PDK) inhibitor dichloroacetate reverses dysregulated hepatocyte metabolism and mitochondrial dysfunction. In summary, our data indicate that sepsis promotes hepatic metabolic dysfunction and that targeting the mitochondrial PDC/PDK energy homeostat rebalances transcriptional and metabolic manifestations of sepsis within the liver.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2021 (prima pubblicazione 2021-02-22).
Identificativi: PMID 33616039 · PMCID PMC7901874 · DOI 10.7554/elife.64611.
Parole chiave degli autori: Liver; Metabolism; Mouse; Sepsis; Inflammation; immunology; Steatosis.
Pagina: https://europepmc.org/article/MED/33616039 — https://doi.org/10.7554/elife.64611. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T20:34:51.361Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.